ARCHIVES

DCE Board Ok’s New RFA Programs worth $14 Million

This article is from The Cancer Letter archive.

Vol. 16 No. 26 | June 29, 1990

Download PDF Visit The Full Archive

Related Articles

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012

The Cancer Letter takes two-week break; next issue Jan. 2.

December 12, 2003

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

NCI Told To “Cut Out The Nonsense,” Adequately Fund Programs At Centers Required By Mandates

November 5, 1976

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012